ArticleCurrent eye research2014
Prediction of glaucomatous visual field progression: pointwise analysis.
Article in Current eye research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed.
- Glaucoma case finding and management among optometrists in Ghana and Nigeria.Optometry and vision science : official publication of the American Academy of Optometry · 2025Article
- Central Corneal Thickness and Glaucoma Risk: The Importance of Corneal Pachymetry in Screening Adults Over 50 and Glaucoma Suspects.Clinical ophthalmology (Auckland, N.Z.) · 2025Review
- Exploring the Ocular Surface Microbiome and Tear Proteome in Glaucoma.International journal of molecular sciences · 2024Article
- Review
- Primary Open Angle Glaucoma Diagnosis Using Pattern Electroretinogram Parameters.Clinical ophthalmology (Auckland, N.Z.) · 2023Article
- Application of a deep learning system in glaucoma screening and further classification with colour fundus photographs: a case control study.BMC ophthalmology · 2022Article
- Pointwise and Region-Wise Course of Visual Field Loss in Patients With Glaucoma.Translational vision science & technology · 2022Article
- Protein Biomarkers in Glaucoma: A Review.Journal of clinical medicine · 2021Review
- Comparison of Medical Comorbidity between Patients with Normal-Tension Glaucoma and Primary Open-Angle Glaucoma: A Population-Based Study in Taiwan.Healthcare (Basel, Switzerland) · 2021Article
- Loss of the Extracellular Matrix Molecule Tenascin-C Leads to Absence of Reactive Gliosis and Promotes Anti-inflammatory Cytokine Expression in an Autoimmune Glaucoma Mouse Model.Frontiers in immunology · 2020Article
- Analysis of pattern electroretinogram signals of early primary open-angle glaucoma in discrete wavelet transform coefficients domain.International ophthalmology · 2019Article
- A Method Using Goldmann Stimulus Sizes I to V-Measured Sensitivities to Predict Lead Time Gained to Visual Field Defect Detection in Early Glaucoma.Translational vision science & technology · 2018Article
- Annexins in Glaucoma.International journal of molecular sciences · 2018Review
- Baseline 24-2 Central Visual Field Damage Is Predictive of Global Progressive Field Loss.American journal of ophthalmology · 2018Article
- Clinical Utility of Optical Coherence Tomography in Glaucoma.Investigative ophthalmology & visual science · 2016Review
- [Functional disorders in the chronological progression of glaucoma].Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft · 2015Review
- Glaucoma history and risk factors.Journal of optometryReview
- Functional assessment of glaucoma: Uncovering progression.Survey of ophthalmologyReview
- Real-world results of the Zeiss selective laser trabeculoplasty in adult South African primary open-angle glaucoma patients.Therapeutic advances in ophthalmologyArticle
- The "Topography" of Glaucomatous Defect Using OCT and Visual Field Examination.Journal of current glaucoma practiceArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
purposeTo evaluate whether pointwise regression analysis of serial measures of retinal sensitivity can predict future visual field (VF) loss.
methodsMedical records of 158 patients with glaucomatous eyes with at least 6 years follow-up and 10 reliable VF exams were retrospectively analyzed. The entire follow-up period was divided into two, roughly corresponding to the first (early period) and second (late period) half of follow-up. Retinal sensitivity data obtained from the Swedish interactive threshold algorithm standard or full-threshold VF tests were analyzed, and linear and first-order exponential regression analyses of retinal sensitivity against time were performed to obtain the slope of regression analysis in each VF test location. Paired t tests were used to compare the slopes of the early and late period in each regression analysis.
resultsWhen assessed by linear regression analysis, inferior nasal location showed highest rate of change (-0.52 dB/year) in early period. Late period showed generally faster rate of progression compared to early period. Superior arcuate and superior and inferior nasal locations showed that early and late slopes did not show significant difference (p value, 0.19 ∼ 0.49). Central and edged locations showed significant difference between the two slopes (p value < 0.05). First-order exponential regression analysis showed similar result. DISCUSSION: Superior arcuate and superior and inferior nasal areas in VF had a consistent rate of change of retinal sensitivity, indicating that these locations may have the higher capability for prediction of future deterioration. These results suggest that location should be considered when predicting glaucomatous VF progression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.